Company

Tango Therapeutics, Inc.

TNGX · CIK 0001819133

SEC FORM 4

$15,962.03

Sale of 700 shares at $22.8029 per share.

Reporting Person Newcomb Jessica · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401327 · filed 2026-09-24 · View filing →

SEC FORM 4

$122,238.33

Sale of 5,100 shares at $23.9683 per share.

Reporting Person Newcomb Jessica · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401327 · filed 2026-09-24 · View filing →

SEC FORM 4

$60,412.32

Sale of 2,400 shares at $25.1718 per share.

Reporting Person Newcomb Jessica · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401327 · filed 2026-09-24 · View filing →

SEC FORM 4

$140,400.00

Acquisition (code M) of 27,000 shares at $5.2 per share.

Reporting Person Crystal Adam · Officer Title President, R&D · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-381853 · filed 2026-09-03 · View filing →

SEC FORM 4

$603,909.00

Sale of 27,000 shares at $22.3670 per share.

Reporting Person Crystal Adam · Officer Title President, R&D · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-381853 · filed 2026-09-03 · View filing →